Clinical Trial Update: Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI [Phase 1]

View source ↗

Summary

Phase 1 crossover trial evaluating atorvastatin's effect on irinotecan pharmacokinetics in advanced colorectal cancer patients receiving FOLFIRI has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• atorvastatin (atorvastatin)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Advanced Adenocarcinoma of the Colon or Rectum | Phase 1 | Status: WITHDRAWN